Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 306, Issue 5, 2014, Pages

  Wang, Ying ^a   Liu, Limei ^b   Du, Hanze ^a,c   Nagaoka, Yoshiko ^d   Fan, Winnie ^a   Lutfy, Kabirullah ^a,e   Friedman, Theodore C ^a   Jiang, Meisheng ^d   Liu, Yanjun ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

11 hydroxysteroid dehydrogenase type 1; Transgenic mouse

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; FATTY ACID BINDING PROTEIN 4; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HORMONE SENSITIVE LIPASE; FATTY ACID; FATTY ACID BINDING PROTEIN; GALACTOSE 6 PHOSPHATE DEHYDROGENASE; GALACTOSE-6-PHOSPHATE DEHYDROGENASE; GLUCOCORTICOID; OXIDOREDUCTASE;

ABDOMINAL FAT; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOLYSIS; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; TRANSGENIC MOUSE; WHITE ADIPOSE TISSUE; 11Β-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMAL; BIOSYNTHESIS; GENETICS; LIVER; METABOLISM; OBESITY; PHYSIOLOGY;

11Β-HYDROXYSTEROID DEHYDROGENASE TYPE 1; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; CARBOHYDRATE DEHYDROGENASES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; GLUCOCORTICOIDS; INSULIN RESISTANCE; LIPOLYSIS; LIVER; MALE; MICE; MICE, TRANSGENIC;

EID: 84899571844     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00491.2013     Document Type: Article

References (50)

1. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17: 245-261, 1996.
2. Belfrage P. Hormonal control of lipid degradation. In: New Perspectives in Adipose Tissue, edited by Cryer A, Van RLR. London, UK: Butterworths, 1985, p. 121-144.
3. Bhat BG, Younis H, Herrera J, Palacio K, Pascual B, Hur G, Jessen B, Ogilvie KM, Rejto PA. Antisense inhibition of 11betahydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model. Biochem Biophys Res Commun 365: 740-745, 2008.
4. Billing-Marczak K, Buzanska L, Winsky L, Nowotny M, Rudka T, Isaacs K, Belin MF, Kuznicki J. AP2-like cis element is required for calretinin gene promoter activity in cells of neuronal phenotype differentiated from multipotent human cell line DEV. Biochim Biophys Acta 1577: 412-420, 2002.
5. Bujalska IJ, Gathercole LL, Tomlinson JW, Darimont C, Ermolieff J, Fanjul AN, Rejto PA, Stewart PM. A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis. J Endocrinol 197: 297-307, 2008.
6. Bujalska IJ, Hewitt KN, Hauton Lavery GG D, Tomlinson JW, Walker EA, Stewart PM. Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue. Endocrinology 149: 2584-2591, 2008.
7. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349: 1210-1213, 1997.
8. Campbell JE, Fediuc S, Hawke TJ, Riddell MC. Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis. Metabolism 58: 651-660, 2009.
9. Campbell JE, Peckett AJ, D'souza AM, Hawke TJ, Riddell MC. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am J Physiol Cell Physiol 300: C198-C209, 2011.
10. Caviglia JM, Betters JL, Dapito DH, Lord CC, Sullivan S, Chua S, Yin T, Sekowski A, Mu H, Shapiro L, Brown JM, Brasaemle DL. Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity. J Lipid Res 52: 2032-2042, 2011.
11. Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40: 967-972, 1999.
12. Cushman SW. Structure-function relationships in the adipose cell. I. Ultrastructure of the isolated adipose cell. J Cell Biol 46: 326-341, 1970.
13. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28: 1039-1049, 2008.
14. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34: 434-439, 2003.
15. Du H, Liu L, Wang Y, Nakagawa Y, Lyzlov A, Lutfy K, Friedman TC, Peng X, Liu Y. Specific reduction of G6PT may contribute to downregulation of hepatic 11beta-HSD1 in diabetic mice. J Mol Endocrinol 50: 167-178, 2013.
16. Dzyakanchuk AA, Balázs Z, Nashev LG, Amrein KE, Odermatt A. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP and is stimulated by extracellular glucose. Mol Cell Endocrinol 301: 137-141, 2009.
17. Fortier M, Soni K, Laurin N, Wang SP, Mauriège P, Jirik FR, Mitchell GA. Human hormone-sensitive lipase (HSL): expression in white fat corrects the white adipose phenotype of HSL-deficient mice. J Lipid Res 46: 1860-1867, 2005.
18. Gout J, Tirard J, Thévenon C, Riou JP, Bégeot M, Naville D. CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11beta-hydroxysteroid dehydrogenase encoding gene in adipose cells. Biochimie 88: 1115-1124, 2006.
19. Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84: 1663-1670, 1989.
20. Hewitt KN, Walker EA, Stewart PM. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11_-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146: 2539-2543, 2005.
21. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
22. Kang SM, Yoon JW, Ahn HY, Kim SY, Lee KH, Shin H, Choi SH, Park KS, Jang HC, Lim S. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. PLoS One 6: e27694, 2011.
23. Kim J, Temple KA, Jones SA, Meredith KN, Basko JL, Brady MJ. Differential modulation of 3T3-L1 adipogenesis mediated by 11betahydroxysteroid dehydrogenase-1 levels. J Biol Chem 282: 11038-11046, 2007.
24. Krssak M, Petersen KF, Dresner A, DiPietro L, Rothman DL. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999.
25. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC, Stewart PM. Hexose-6-phosphate dehydrogenase knock-outmice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 281: 6546-6551, 2006.
26. Liu Y, Nakagawa Y, Wang Y, Liu L, Du H, Wang W, Ren X, Lutfy K, Friedman TC. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J Mol Endocrinol 41: 53-64, 2008.
27. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705, 2001.
28. Mårin P, Darin N, Amemiya T, Andersson B, Jern S, Björntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41: 882-886, 1992.
29. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166-2170, 2001.
30. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112: 83-90, 2003.
31. McCormick KL, Wang X, Mick GJ. Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes. J Biol Chem 281: 341-347, 2006.
32. Mziaut H, Korza G, Hand AR, Gerard C, Ozols J. Targeting proteins to the lumen of endoplasmic reticulum using N-terminal domains of 11beta-hydroxysteroid dehydrogenase and the 50-kDa esterase. J Biol Chem 274: 14122-14129, 1999.
33. Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE. 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J Steroid Biochem Mol Biol 64: 251-260, 1998.
34. Odermatt A, Arnold P, Stauffer A, Frey BM, Frey FJ. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J Biol Chem 274: 28762-28770, 1999.
35. Park J, Choe SS, Choi AH, Yoo MJ, Suganam T, Ogawa Y, Kim JB. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes 55: 2939-2949, 2006.
36. Rangwala SM, Lazar MA. Transcriptional control of adipogenesis. Annu Rev Nutr 20: 535-559, 2000.
37. Rönquist-Nii Y, Edlund PO. Determination of corticosteroids in tissue samples byliquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 37: 341-350, 2005.
38. Sano S, Nakagawa Y, Yamaguchi R, Fujisawa Y, Satake E, Nagata E, Nakanishi T, Liu YJ, Ohzeki T. Carbenoxolone alters the morphology of adipose tissues and downregulates genes involved in adipogenesis, glucose transport and lipid metabolism in high-fat diet-fed mice. Horm Metab Res 44: 15-20, 2012.
39. Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. Circ J 73: 27-34, 2009.
40. Slavin BG, Ong JM, Kern PA. Hormonal regulation of hormonesensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res 35: 1535-1541, 1994.
41. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84: 1022-1027, 1999.
42. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids 63: 319-321, 1998.
43. Tae HJ, Zhang S, Kim KH. cAMP activation of CAAT enhancer-binding protein-beta gene expression and promoter I of acetyl-CoA carboxylase. J Biol Chem 270: 21487-21494, 1995.
44. Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, Courtney R, Rejto P, Carley W, Stewart PM. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. J Clin Endocrinol Metab 92: 857-864, 2007.
45. Uçkaya G, Karadurmuş N, Kutlu O, Corakçi A, Kizildaǧ S, Ural AU, Gül D, Kutlu M. Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 82, Suppl 2: S135-S140, 2008.
46. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 279: 47066-47075, 2004.
47. Wang Y, Nakagawa Y, Liu L, Wang W, Ren X, Anghel A, Lutfy K, Friedman TC, Liu Y. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia 54: 440-450, 2011.
48. Williams LJ, Lyons V, MacLeod I, Rajan V, Darlington GJ, Poli V, Seckl JR, Chapman KE. C/EBP regulates hepatic transcription of 11beta-hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. J Biol Chem 275: 30232-30239, 2000.
49. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeo C, Spiegelman BM. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3: 151-158, 1999.
50. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168-181, 1995.